He describes the science behind ITK, and goes over ASH data in r/r T-cell lymphoma, where the company is already enrolling a pivotal study. Plus, why the profile of ITK in oncology gives him confidence in its utility for autoimmune disease, and highlighting atopic dermatitis data that will be coming in January.
View all episodes
By BiotechTV
4.3
66 ratings
He describes the science behind ITK, and goes over ASH data in r/r T-cell lymphoma, where the company is already enrolling a pivotal study. Plus, why the profile of ITK in oncology gives him confidence in its utility for autoimmune disease, and highlighting atopic dermatitis data that will be coming in January.
3,374 Listeners
426 Listeners
1,644 Listeners
938 Listeners
125 Listeners
321 Listeners
213 Listeners
6,444 Listeners
61 Listeners
9,855 Listeners
86 Listeners
34 Listeners
19 Listeners
0 Listeners
4 Listeners
2 Listeners
5 Listeners
49 Listeners